Company Filing History:
Years Active: 2016
Title: Craig B Skinner: Innovator in Monoclonal Antibodies
Introduction
Craig B Skinner is a notable inventor based in Novato, California. He has made significant contributions to the field of biotechnology, particularly in the development of high affinity monoclonal antibodies. His work has implications for medical diagnostics and treatment.
Latest Patents
Craig B Skinner holds a patent for "High affinity monoclonal antibodies for detection of shiga toxin 2." This patent describes high affinity monoclonal antibodies against Stx2f and hybridomas that produce such antibodies. The antibodies can be utilized in a kit for detecting Stx2f and its variants in samples, as well as for neutralizing Shiga toxin in vivo.
Career Highlights
Skinner is associated with the United States of America, as represented by the Secretary of Agriculture. His work has been instrumental in advancing the understanding and detection of Shiga toxin, which is crucial for public health.
Collaborations
He has collaborated with notable colleagues, including Xiaohua He and Larry H Stanker, to further enhance the research and development of monoclonal antibodies.
Conclusion
Craig B Skinner's innovative work in monoclonal antibodies showcases his commitment to advancing medical science and improving health outcomes. His contributions are vital in the ongoing fight against diseases caused by Shiga toxin.